A Study of HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function

Summary

The primary objective of this study is to evaluate pharmacokinetics of HRS-1301 tablets in subjects with impaired kidney function in comparison with healthy subjects, to develop dose recommendations for patients with renal impairment.

Timeline

Start

2026-01-13

Primary completion

2026-10

Completion

2026-10

Drugs

Indications